Why CVC

Vendor selection matters because recruitment, quality, and delivery do not fail in isolation.

CVC gives sponsor teams a more credible source of truth for vendor selection: evidence, fit, recurring failure patterns, and a clearer route from longlist to shortlist.

Recruitment Timeline pressure compounds quickly when vendor fit is weak.

Quality Oversight still sits with the sponsor even when work is outsourced.

Relationship High-performing trials need operating partners, not just transactional suppliers.

Why selection matters

Recruitment delay, avoidable protocol change, and poor qualification all hit the same programme.

Weak vendor selection rarely shows up as one isolated issue. It shows up as slower recruitment, more amendments, more governance burden, and lower confidence in the operating relationship.

Recruitment pressure affects timelines, cost, and study confidence.
Quality issues often surface when oversight, fit, and execution are misaligned.
Vendor relationships work better when they are managed as operational partnerships rather than transactional buying events.

Evidence signals

What the data says

~80%

of trials fail to meet the initial enrollment target and timeline.

57%

of protocols in one Tufts CSDD analysis had at least one substantial amendment.

19-26 weeks

average vendor qualification cycle time from RFI to signed contract in Tufts CSDD benchmarking.

At a glance

Selection quality shows up in time, cost, and sponsor oversight burden.

~80%

Trials in one cited review missed initial enrollment target and timeline.

US $8m/day

Potential revenue impact cited in the same recruitment-delay literature.

57%

Protocols in one Tufts CSDD analysis had at least one substantial amendment.

7%-14%

Trials affected by vendor qualification delays in Tufts CSDD benchmark reporting.

How CVC works

Move from need definition to shortlist with more structure.

Not transactional procurement Selection with evidence, fit, and recurring risk visible

Define the study need

Set sponsor constraints, programme pressure points, and the real vendor mix needed.

Screen the market

Cut the universe by vendor type, phase fit, region, review score, and operating scale.

Compare evidence

Carry the right vendors into compare and keep strengths, weaknesses, and quality signals visible.

Move to shortlist action

Launch an RFP, moderate bids, or defend a selection against governance and timing pressure.

Why buyers use CVC

Selection should be defensible, not just fast.

Choose vendors faster with one surface for score, fit, and evidence.
Compare with more confidence using explicit criteria and recurring weakness signals.
Use peer experience without confusing public online sentiment with validated platform review.
Create stronger longlist and shortlist decisions with visible rationale.

Source notes

Reference points used on this page

These references are used to support the page narrative. CVC’s interpretation is that vendor selection quality affects recruitment, amendment burden, governance effort, and sponsor oversight risk.

Why reviews matter

Evidence gets stronger when operators contribute structured review data.

CVC’s review layer is designed to capture what sponsor teams actually need during selection: delivery reliability, therapeutic fit, compliance, reporting quality, responsiveness, value, and collaboration, supported by written context.

Separate platform-reviewed evidence from generic online sentiment.
Make recurring strengths and failure patterns visible across vendors.
Add sponsor-credible context instead of anonymous star-only scoring.

Next step

Start with a sponsor brief, then shortlist against evidence rather than noise.

Open sponsor RFP Browse vendor directory